EEG Effects of Buspirone and Pindolol: a Method of Examining 5-HT1A Receptor Function in Humans

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 2003 Feb 18

PMID 12589521

Citations 7

Authors

R H McAllister-Williams

A E Massey

Affiliations

Soon will be listed here.

Abstract

Rationale: An involvement of 5-HT(1A) receptors is postulated in the pathophysiology of affective disorders and mechanism of action of antidepressants. Methods for studying their functional integrity in humans are, however, limited. Preliminary data suggests that activation of somatodendritic 5-HT(1A) receptors cause a negative shift in the EEG frequency spectrum. Animal research suggests that pindolol is an agonist at these receptors but an antagonist at postsynaptic 5-HT(1A) receptors.

Objective: We postulated that while pindolol would antagonise known postsynaptic mediated neuroendocrine responses to the 5-HT(1A) agonist buspirone, both drugs would have a similar effect on the EEG frequency spectrum.

Methods: Fourteen healthy men were administered placebo or pindolol (20 mg orally) 90 min before placebo or buspirone (30 mg orally) in a double blind cross-over study. Plasma prolactin and growth hormone were assayed and EEGs recorded before and after drug administration.

Results: A significant negative shift in the EEG frequency spectrum was found for both buspirone and pindolol, with the combination producing a similar effect to each drug alone. In contrast, the neuroendocrine response to buspirone was significantly attenuated by pindolol.

Conclusions: The data obtained are consistent with the EEG effects of buspirone and pindolol being mediated by somatodendritic 5-HT(1A) receptors, in contrast to the neuroendocrine response, which is known to be mediated by postsynaptic receptors. The development of this novel method of assessing somatodendritic 5-HT(1A) receptors in humans is a potentially important advance which may allow the testing of hypotheses of its involvement in depression and response to antidepressants.

Citing Articles

The behavioural effects of the serotonin 1A receptor agonist buspirone on cognition and emotional processing in healthy volunteers.

Smith A, Hamilton S, Murphy S, Cowen P, Harmer C Psychopharmacology (Berl). 2025; .

PMID: 40087174 DOI: 10.1007/s00213-025-06770-6.

Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats.

Tyls F, Vejmola C, Koudelka V, Piorecka V, Kaderabek L, Bochin M Front Neurosci. 2023; 17:1152578.

PMID: 37425017 PMC: 10325866. DOI: 10.3389/fnins.2023.1152578.

The Serotonin 1A (5-HT) Receptor as a Pharmacological Target in Depression.

Smith A, Harmer C, Cowen P, Murphy S CNS Drugs. 2023; 37(7):571-585.

PMID: 37386328 DOI: 10.1007/s40263-023-01014-7.

Serotonin Neuronal Function from the Bed to the Bench: Is This Really a Mirrored Way?.

Etievant A, Lau T, Lucas G, Haddjeri N eNeuro. 2019; 6(3).

PMID: 31118207 PMC: 6553573. DOI: 10.1523/ENEURO.0021-19.2019.

Elevated CYP2C19 expression is associated with depressive symptoms and hippocampal homeostasis impairment.

Jukic M, Opel N, Strom J, Carrillo-Roa T, Miksys S, Novalen M Mol Psychiatry. 2016; 22(8):1155-1163.

PMID: 27895323 DOI: 10.1038/mp.2016.204.

References

Corradetti R, Laaris N, Hanoun N, Laporte A, Le Poul E, Hamon M . Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain. Br J Pharmacol. 1998; 123(3):449-62. PMC: 1565192. DOI: 10.1038/sj.bjp.0701632. View

UPADHYAYA A, Pennell I, Cowen P, Deakin J . Blunted growth hormone and prolactin responses to L-tryptophan in depression; a state-dependent abnormality. J Affect Disord. 1991; 21(3):213-8. DOI: 10.1016/0165-0327(91)90042-q. View

Gillin J, Jernajczyk W, Golshan S, Lardon M, Stahl S . Inhibition of REM sleep by ipsapirone, a 5HT1A agonist, in normal volunteers. Psychopharmacology (Berl). 1994; 116(4):433-6. DOI: 10.1007/BF02247474. View

Anderer P, Barbanoj M, Saletu B, Semlitsch H . Restriction to a limited set of EEG-target variables may lead to misinterpretation of pharmaco-EEG results. Neuropsychobiology. 1993; 27(2):112-6. DOI: 10.1159/000118963. View

Pitchot W, Ansseau M, Gonzalez Moreno A, Lembreghts M, Hansenne M, Wauthy J . The flesinoxan 5-HT1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry. 1995; 28 Suppl 2:91-2. DOI: 10.1055/s-2007-979625. View

Mizuki Y, Suetsugi M, Ushijima I, Yamada M . Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity. Methods Find Exp Clin Pharmacol. 1994; 16(4):291-300. View

Meltzer H, Maes M . Effect of pindolol on hormone secretion and body temperature: partial agonist effects. J Neural Transm (Vienna). 1996; 103(1-2):77-88. DOI: 10.1007/BF01292618. View

Semlitsch H, Anderer P, Schuster P, Presslich O . A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology. 1986; 23(6):695-703. DOI: 10.1111/j.1469-8986.1986.tb00696.x. View

Pasqualetti M, Nardi I, Ladinsky H, Marazziti D, Cassano G . Comparative anatomical distribution of serotonin 1A, 1D alpha and 2A receptor mRNAs in human brain postmortem. Brain Res Mol Brain Res. 1996; 39(1-2):223-33. DOI: 10.1016/0169-328x(96)00026-5. View

10.

Young A, Sharpley A, Campling G, Hockney R, Cowen P . Effects of hydrocortisone on brain 5-HT function and sleep. J Affect Disord. 1994; 32(2):139-46. DOI: 10.1016/0165-0327(94)90072-8. View

11.

Arango V, Underwood M, Boldrini M, Tamir H, Kassir S, Hsiung S . Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology. 2001; 25(6):892-903. DOI: 10.1016/S0893-133X(01)00310-4. View

12.

Shapira B, Newman M, Gelfin Y, Lerer B . Blunted temperature and cortisol responses to ipsapirone in major depression: lack of enhancement by electroconvulsive therapy. Psychoneuroendocrinology. 2000; 25(5):421-38. DOI: 10.1016/s0306-4530(99)00067-0. View

13.

Martin K, Phillips I, Hearson M, Prow M, Heal D . Characterization of 8-OH-DPAT-induced hypothermia in mice as a 5-HT1A autoreceptor response and its evaluation as a model to selectively identify antidepressants. Br J Pharmacol. 1992; 107(1):15-21. PMC: 1907611. DOI: 10.1111/j.1476-5381.1992.tb14457.x. View

14.

Seletti B, Benkelfat C, Blier P, Annable L, Gilbert F, De Montigny C . Serotonin1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology. 1995; 13(2):93-104. DOI: 10.1016/0893-133X(95)00025-9. View

15.

Cowen P, Charig E . Neuroendocrine responses to intravenous tryptophan in major depression. Arch Gen Psychiatry. 1987; 44(11):958-66. DOI: 10.1001/archpsyc.1987.01800230038008. View

16.

Aghajanian G, VanderMaelen C . Intracellular recordings from serotonergic dorsal raphe neurons: pacemaker potentials and the effect of LSD. Brain Res. 1982; 238(2):463-9. DOI: 10.1016/0006-8993(82)90124-x. View

17.

Clifford E, Gartside S, Umbers V, Cowen P, Hajos M, Sharp T . Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo. Br J Pharmacol. 1998; 124(1):206-12. PMC: 1565357. DOI: 10.1038/sj.bjp.0701796. View

18.

Checkley S . Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med. 1980; 10(1):35-53. DOI: 10.1017/s0033291700039593. View

19.

Seifritz E, Gillin J, Rapaport M, Kelsoe J, Bhatti T, Stahl S . Sleep electroencephalographic response to muscarinic and serotonin1A receptor probes in patients with major depression and in normal controls. Biol Psychiatry. 1998; 44(1):21-33. DOI: 10.1016/s0006-3223(97)00551-9. View

20.

Azmitia E, Gannon P, Kheck N, Whitaker-Azmitia P . Cellular localization of the 5-HT1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology. 1996; 14(1):35-46. DOI: 10.1016/S0893-133X(96)80057-1. View